Is it growing?
Is ALKS growing?
Alkermes plc has grown revenue 12% a year over three years and 8.4% a year over five.
+12%
Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +15% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue
- Revenue growth, 5-year rate
- +8.4%
Revenue growth, 5-year rate · +12% over three · growth has picked up over the last three years
- Years of annual history on file
- 16
Years of annual history on file · FY2009 to FY2025, as filed
Details›
- Revenue FY2021
- $1.17B
- Revenue FY2022
- $1.11B
- Revenue FY2023
- $1.66B
- Revenue FY2024
- $1.56B
- Revenue FY2025
- $1.48B
Annual income statements as filed with the SEC.
Drug Manufacturers - Specialty & Generic
Ranks #21 of 28 by Smart Score